苏沃雷生用于治疗阿尔茨海默病患者的失眠症。 - Suppr

Suppr

超能文献

Suvorexant for the treatment of insomnia in patients with Alzheimer's disease.

作者信息

Hamuro Atsushi, Honda Minoru, Wakaura Yuya

机构信息

1 Department of Psychiatry, Yuzuriha Hospital, Nagasaki, Japan.

2 Department of Nursing, Yuzuriha Hospital, Nagasaki, Japan.

出版信息

Aust N Z J Psychiatry. 2018 Feb;52(2):207-208. doi: 10.1177/0004867417747402. Epub 2017 Dec 14.

DOI:10.1177/0004867417747402

PMID:29237271

Abstract

摘要

相似文献

Suvorexant for the treatment of insomnia in patients with Alzheimer's disease.

Aust N Z J Psychiatry. 2018 Feb;52(2):207-208. doi: 10.1177/0004867417747402. Epub 2017 Dec 14.

Suvorexant: scientifically interesting, utility uncertain.

Australas Psychiatry. 2017 Dec;25(6):622-624. doi: 10.1177/1039856217734677. Epub 2017 Oct 10.

[Preclinical and clinical results of dual orexin receptor antagonist, suvorexant (BELSOMRA(®)), a novel therapeutic agent for insomnia].

Nihon Yakurigaku Zasshi. 2016 Jul;148(1):46-56. doi: 10.1254/fpj.148.46.

Suvorexant in Patients With Insomnia: Results From Two 3-Month Randomized Controlled Clinical Trials.

Biol Psychiatry. 2016 Jan 15;79(2):136-48. doi: 10.1016/j.biopsych.2014.10.003. Epub 2014 Oct 23.

Effects of suvorexant on the Insomnia Severity Index in patients with insomnia: analysis of pooled phase 3 data.

Sleep Med. 2019 Apr;56:219-223. doi: 10.1016/j.sleep.2018.09.010. Epub 2018 Oct 2.

The role of suvorexant in the prevention of delirium during acute hospitalization: A systematic review.

J Crit Care. 2020 Oct;59:1-5. doi: 10.1016/j.jcrc.2020.05.006. Epub 2020 May 20.

Suvorexant-Induced Delirium.

Prim Care Companion CNS Disord. 2018 Nov 15;20(6):18l02297. doi: 10.4088/PCC.18l02297.

Suvorexant as an orexin antagonist may regulate serum glucose levels in psychiatric patients with insomnia.

Psychiatry Clin Neurosci. 2017 Dec;71(12):844. doi: 10.1111/pcn.12608. Epub 2017 Nov 9.

Suvorexant: efficacy and safety profile of a dual orexin receptor antagonist in treating insomnia.

Drugs Today (Barc). 2016 Jan;52(1):29-40. doi: 10.1358/dot.2016.52.1.2439940.

Orexin receptor antagonists for the treatment of insomnia and potential treatment of other neuropsychiatric indications.

J Sleep Res. 2019 Apr;28(2):e12782. doi: 10.1111/jsr.12782. Epub 2018 Oct 18.

引用本文的文献

Protocol and design of the REPOSE study: a double-blinded, randomised, placebo-controlled trial to evaluate the efficacy of suvorexant to improve postoperative sleep and reduce delirium severity in older patients undergoing non-cardiac surgery.

BMJ Open. 2025 Mar 13;15(3):e091099. doi: 10.1136/bmjopen-2024-091099.

Orexin Receptor Antagonists for the Prevention and Treatment of Alzheimer's Disease and Associated Sleep Disorders.

Drugs. 2024 Nov;84(11):1365-1378. doi: 10.1007/s40265-024-02096-3. Epub 2024 Oct 4.

Integrating lived experience to develop a tailored sleep intervention for people living with dementia and carepartners.

Dementia (London). 2025 May;24(4):697-719. doi: 10.1177/14713012241282769. Epub 2024 Sep 9.

Effects of new hypnotic drugs on cognition: A systematic review and network meta-analysis.

Sleep Med X. 2023 Nov 19;6:100094. doi: 10.1016/j.sleepx.2023.100094. eCollection 2023 Dec 15.

Factors Associated with Prescriptions for an Orexin Receptor Antagonist Among Japanese Patients with Insomnia: Analysis of a Nationwide Japanese Claims Database.

Drugs Real World Outcomes. 2023 Jun;10(2):271-281. doi: 10.1007/s40801-023-00356-4. Epub 2023 Mar 3.

Suvorexant, a Novel Dual Orexin Receptor Antagonist, for the Management of Insomnia.

Health Psychol Res. 2023 Jan 28;10(5):67898. doi: 10.52965/001c.67898. eCollection 2022.

Orexin A peptidergic system: comparative sleep behavior, morphology and population in brains between wild type and Alzheimer's disease mice.

Brain Struct Funct. 2022 Apr;227(3):1051-1065. doi: 10.1007/s00429-021-02447-w. Epub 2022 Jan 23.

Pharmacotherapies for sleep disturbances in dementia.

Cochrane Database Syst Rev. 2020 Nov 15;11(11):CD009178. doi: 10.1002/14651858.CD009178.pub4.

Therapy for Insomnia and Circadian Rhythm Disorder in Alzheimer Disease.

Curr Treat Options Neurol. 2020 Feb 5;22(2):4. doi: 10.1007/s11940-020-0612-z.

Orexin Receptor Antagonists as Emerging Treatments for Psychiatric Disorders.

Neurosci Bull. 2020 Apr;36(4):432-448. doi: 10.1007/s12264-019-00447-9. Epub 2019 Nov 28.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验